PURPOSE OF REVIEW This brief critical review evaluates recent research on the impact of anxiety disorders and post-traumatic stress disorders (PTSD) on patients with chronic obstructive pulmonary disease (COPD) and asthma. In these patients, untreated anxiety and PTSD exacerbate acute symptoms, increase disability and impair quality of life. Therefore, effective interventions are also reviewed. RECENT FINDINGS Anxiety disorders and PTSD are prevalent in COPD and asthma, worsen symptoms in acute exacerbations, and increase morbidity and healthcare utilization. Pulmonary rehabilitation (PR), cognitive behavioural therapy and pharmacological therapy are each effective in COPD patients with anxiety or PTSD. However, very little work examined therapy for combined anxiety and PTSD in patients with either COPD or asthma. SUMMARY Despite the high prevalence of anxiety disorder or PTSD in patients with chronic respiratory diseases, a paucity of literature remains demonstrating the efficacy of pharmacological therapies for these conditions. This review highlights the promising benefits of PR on anxiety, but prospective trials are needed to demonstrate the efficacy of interventions with PTSD alone, or with concomitant anxiety.

中文翻译：

---

慢性呼吸道疾病患者的焦虑和创伤后应激障碍。

综述目的这篇简短的批判性综述评估了关于焦虑症和创伤后应激障碍（PTSD）对慢性阻塞性肺病（COPD）和哮喘患者影响的最新研究。在这些患者中，未经治疗的焦虑和创伤后应激障碍会加剧急性症状，增加残疾并损害生活质量。因此，还审查了有效的干预措施。最新发现焦虑症和创伤后应激障碍 (PTSD) 在慢性阻塞性肺病 (COPD) 和哮喘中普遍存在，在急性发作时会使症状恶化，并增加发病率和医疗保健利用率。肺康复（PR）、认知行为疗法和药物疗法对于伴有焦虑或创伤后应激障碍（PTSD）的慢性阻塞性肺病（COPD）患者均有效。然而，很少有研究针对慢性阻塞性肺病或哮喘患者的焦虑和创伤后应激障碍的治疗进行研究。摘要 尽管慢性呼吸系统疾病患者焦虑症或创伤后应激障碍（PTSD）的患病率很高，但仍缺乏文献证明药物治疗对这些疾病的有效性。这篇综述强调了 PR 对焦虑的潜在益处，但需要前瞻性试验来证明单独干预 PTSD 或伴随焦虑的干预措施的有效性。